SC 13G/A: ProMIS Neurosciences Inc.

Ticker: PMN · Form: SC 13G/A · Filed: Nov 6, 2024 · CIK: 1374339

Promis Neurosciences Inc. SC 13G/A Filing Summary
FieldDetail
CompanyPromis Neurosciences Inc. (PMN)
Form TypeSC 13G/A
Filed DateNov 6, 2024
Risk Levellow
Pages10
Reading Time12 min
Key Dollar Amounts$1.75, $14 m, $2.02, $2.50
Sentimentneutral

Sentiment: neutral

Topics: sc-13g-a

AI Summary

SC 13G/A filing by ProMIS Neurosciences Inc..

Risk Assessment

Risk Level: low

FAQ

What type of filing is this?

This is a SC 13G/A filing submitted by Promis Neurosciences Inc. (ticker: PMN) to the SEC on Nov 6, 2024.

What is the risk level of this SC 13G/A filing?

This filing has been assessed as low risk.

What are the key financial figures in this filing?

Key dollar amounts include: $1.75 (2023 Warrants have an exercise price of $1.75 per whole warrant, are currently exerci); $14 m (qualified equity financing in excess of $14 million, the Series 2 Preferred Shares in); $2.02 (he A Warrants have an exercise price of $2.02 per warrant share, are currently exerci); $2.50 (he C Warrants have an exercise price of $2.50 per warrant share, are currently exerci).

How long is this filing?

Promis Neurosciences Inc.'s SC 13G/A filing is 10 pages with approximately 2,878 words. Estimated reading time is 12 minutes.

Where can I view the full SC 13G/A filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 2,878 words · 12 min read · ~10 pages · Grade level 9 · Accepted 2024-11-06 16:15:57

Key Financial Figures

  • $1.75 — 2023 Warrants have an exercise price of $1.75 per whole warrant, are currently exerci
  • $14 m — qualified equity financing in excess of $14 million, the Series 2 Preferred Shares in
  • $2.02 — he A Warrants have an exercise price of $2.02 per warrant share, are currently exerci
  • $2.50 — he C Warrants have an exercise price of $2.50 per warrant share, are currently exerci

Filing Documents

Ownership

Item 4. Ownership A. Jeremy M. Sclar (i) Mr. Sclar may be deemed the beneficial owner of 6,372,397 Common Shares, consisting of (a) 65,000 Common Shares owned by Mr. Sclar individually, (b) 1,005,726 Common Shares (the " CM Common Shares ") owned by Crocker Mountain, 150,000 CM Conversion Shares, , 85,208 Common Shares underlying warrants (the " Initial CM Warrants ") owned by Crocker Mountain to purchase Common Shares, which are currently exercisable and 664,893 Common Shares underlying the August 2023 Warrants owned by Crocker Mountain (the " CM August 2023 Warrants ") to purchase Common Shares, which are currently exercisable and (c) 150,000 JS Trust Conversion Shares, 1,467,437 Common Shares (the " JS Trust Common Shares ") owned by the JS Trust, 26,217 Common Shares underlying warrants (the " JS Trust October 2022 Warrants ") owned by the JS Trust to purchase Common Shares, which are currently exercisable, 664,894 Common Shares underlying the August 2023 Warrants owned by the JS Trust (the " JS Trust August 2023 Warrants ") to purchase Common Shares, which are currently exercisable, 697,674 Common Shares underlying the July 2024 Tranche A Warrants, which are currently exercisable, 697,674 Common Shares underlying the July 2024 Tranche B Warrants, which are currently exercisable and 697,674 Common Shares underlying the July 2024 Tranche C Warrants, which are currently exercisable. Mr. Sclar is the sole manager of Crocker Mountain and Mr. Sclar's spouse is one of the trustees of the JS Trust. (ii) Mr. Sclar may be deemed the beneficial owner of approximately 19.1% of the Common Shares outstanding. The percentage of beneficial ownership is based upon 29,885,452 Common Shares outstanding as of August 26, 2024, plus the Common Shares underlying the Initial CM Warrants, the Common Shares underlying the CM August 2023 Warrants, the Common Shares underlying the JS Trust October 2022 Warrants, the Common Shares underlying the JS Trust August 2023 Warrants, the

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.